Cornell researchers have identified a type of immune system cell that prevents a patient’s body from attacking donor cells after a bone marrow transplant.
Susan Daniel and Gary Whittaker discuss their collaborations and others across Cornell’s campuses that are working to better understand the COVID-19 virus.
Well-designed healthcare facilities lead to better patient outcomes that, in turn, result in money saved for facility owners and patients, according to new Cornell research.
Chats in the Stacks book talks this semester at Olin and Mann libraries feature faculty authors discussing politics and economics as the 2016 presidential election approaches, and other topics from poetry to religion.
The end of face masks in public could be a year or more away as questions of transmissibility post-vaccine and effectiveness against emerging strains remain. One thing is clear: when it comes to fit, function, fashion, and sustainability, current face masks leave a lot of room for improvement.
Researchers from the College of Engineering and Weill Cornell Medicine will fight the spread of breast cancer and other cancers with a $9.3M, five-year grant from the National Cancer Institute.
Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.
An experimental drug that blocks the activation of an immune cell component effectively prevented rejection of heart transplants in mice, says new research from scientists at Weill Cornell Medicine.
Years before COVID-19 turned into a global pandemic, biomolecular engineer Susan Daniel was already looking for ways to defeat it. Now she’s expanding her coronavirus studies, blending engineering with virology and data science.